United States · FDA National Drug Code directory
Fosinopril Sodium and Hydrochlorothiazide
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 65862-309_34bf0456-37d0-4d7d-a585-1555b7bc9373
- Product NDC
- 65862-309
- Form
- TABLET
- Composition / generic term
- Fosinopril Sodium and Hydrochlorothiazide
- Labeler
- Aurobindo Pharma Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20090709
- Source listing expiry
- 20261231
Source-listed ingredients
- FOSINOPRIL SODIUM — 20 mg/1
- HYDROCHLOROTHIAZIDE — 12.5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE (65862-309-01) · 65862-309-01
- 30 TABLET in 1 BOTTLE (65862-309-30) · 65862-309-30
- 1000 TABLET in 1 BOTTLE (65862-309-99) · 65862-309-99
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →